Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / BIOTECHNOLOGY
-
Total 13F shares
-
975,538
-
Share change
-
-102,459
-
Total reported value
-
$45,554,572
-
Price per share
-
$46.50
-
Number of holders
-
72
-
Value change
-
-$4,876,335
-
Number of buys
-
17
-
Number of sells
-
35
Institutional Holders of INVESCO EXCHANGE TRADED FD T - BIOTECHNOLOGY (PBE) as of Q1 2020
As of 31 Mar 2020,
INVESCO EXCHANGE TRADED FD T - BIOTECHNOLOGY (PBE) was held by
72 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
975,538 shares.
The largest 10 holders included
MORGAN STANLEY, ROYAL BANK OF CANADA, Advisor Group Holdings, Inc., UBS Group AG, BANK OF AMERICA CORP /DE/, WELLS FARGO & COMPANY/MN, CITADEL ADVISORS LLC, PFG Advisors, CLS Investments, LLC, and YHB Investment Advisors, Inc..
This page lists
73
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.